Francisca Pinheiro
Barcelona, CT 08193, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Mass spectrometry footprinting reveals how kinetic stabilizers counteract transthyretin dynamics altered by pathogenic mutations.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 31, 2025
Design and redesign journey of a drug for transthyretin amyloidosis.
Journal: Neural regeneration research
Published: January 15, 2024
PITB: A high affinity transthyretin aggregation inhibitor with optimal pharmacokinetic properties.
Journal: European journal of medicinal chemistry
Published: July 24, 2023
Author Correction: Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity.
Journal: Nature communications
Published: February 03, 2023
Development of a Highly Potent Transthyretin Amyloidogenesis Inhibitor: Design, Synthesis, and Evaluation.
Journal: Journal of medicinal chemistry
Published: October 28, 2022
The small aromatic compound SynuClean-D inhibits the aggregation and seeded polymerization of multiple α-synuclein strains.
Journal: The Journal of biological chemistry
Published: January 12, 2022
Disease-associated mutations impacting BC-loop flexibility trigger long-range transthyretin tetramer destabilization and aggregation.
Journal: The Journal of biological chemistry
Published: April 06, 2021
Inhibition of α-Synuclein Aggregation and Mature Fibril Disassembling With a Minimalistic Compound, ZPDm.
Journal: Frontiers in bioengineering and biotechnology
Published: July 29, 2020
MIRRAGGE - Minimum Information Required for Reproducible AGGregation Experiments.
Journal: Frontiers in molecular neuroscience
Published: July 12, 2020
Tolcapone, a potent aggregation inhibitor for the treatment of familial leptomeningeal amyloidosis.
Journal: The FEBS journal
Published: February 14, 2020
ZPD-2, a Small Compound That Inhibits α-Synuclein Amyloid Aggregation and Its Seeded Polymerization.
ZPD-2, a Small Compound That Inhibits α-Synuclein Amyloid Aggregation and Its Seeded Polymerization.
Journal: Frontiers in molecular neuroscience
Published: September 10, 2019
Last Updated: 09/26/2026